Active Ingredient(s): Finerenone
FDA Approved: * July 9, 2021
Pharm Company: * BAYER HLTHCARE

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Kerendia Overview

Finerenone, sold under the brand name Kerendia, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.[2] Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA).[1] Common side effects include hyperkalemia (high levels of potassium), hypotension (low blood pres...

Read more Kerendia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Kerendia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 10mg, 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Kerendia: (2 results)

Sorted by National Drug Code
  • 50419-540 Kerendia 10 mg Oral Tablet, Film Coated by Bayer Healthcare Pharmaceuticals Inc.
  • 50419-541 Kerendia 20 mg Oral Tablet, Film Coated by Bayer Healthcare Pharmaceuticals Inc.

Other drugs which contain Finerenone or a similar ingredient: (1 result)